Inhibition of enterotoxigenic Escherichia Coli (ETEC) adhesion to caco-2 cells by human milk and its immunoglobulin and non-immunoglobulin fractions. by Oliveira, Inaiara Rosa de et al.
 All the contents of this site www.scielo.br, except where otherwise noted, is 
licensed under a Creative Commons Attribution License. 
 Todo o conteúdo deste site www.scielo.br, exceto quando identificado, utiliza 
uma Licença de Atribuição Creative Commons. 
 
REFERÊNCIA 
OLIVEIRA, Inaiara R. de. et al. Inhibition of enterotoxigenic Escherichia Coli (ETEC) adhesion to 
caco-2 cells by human milk and its immunoglobulin and non-immunoglobulin fractions, 
Brazilian Journal of Microbiology, São Paulo, v. 38, n. 1, p. :86-92 Jan./Mar. 2007. Disponível 
em:< http://www.scielo.br/pdf/bjm/v38n1/arq18.pdf> Acesso em: 03 fev. 2015. 
http://dx.doi.org/10.1590/S1517-83822007000100018. 
Brazilian Journal of Microbiology (2007) 38:86-92
ISSN 1517-8283
86
INHIBITION OF ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) ADHESION TO CACO-2 CELLS
BY HUMAN MILK AND ITS IMMUNOGLOBULIN AND NON-IMMUNOGLOBULIN FRACTIONS
Inaiara R. de Oliveira1; Heidi C. Bessler1; Sonia N. Bao2; Renato de L. Lima3; Loreny G. Giugliano*1
1Laboratório de Microbiologia, Departamento de Biologia Celular, Instituto de Biologia, Universidade de Brasília, Brasília-DF,
Brazil; 2Laboratório de Microscopia Eletrônica, Departamento de Biologia Celular, Instituto de Biologia, Universidade de
Brasília, Brasília-DF, Brazil; 3Hospital Universitário de Brasília, Departamento de Pediatria, Banco de Leite, Universidade de
Brasília, Brasília-DF, Brazil
Submitted: January 16, 2006; Returned to authors for corrections: March 23, 2006; Approved: January 18, 2007
ABSTRACT
Enterotoxigenic Escherichia coli (ETEC) is the most common cause of diarrhea in children in developing
countries and among travelers to ETEC endemic areas. ETEC diarrhea is caused by colonization of the small
intestine mediated by colonization factor (CF) antigens, and subsequent elaboration of enterotoxins. Breast
feeding has been related to protection against enteric infections. The protective effect of human milk can be
ascribed to its immunoglobulin content, specially secretory immunoglobulin A (sIgA), and to non-
immunoglobulin components such as free oligosaccharides, glycoproteins and glycolipids. In this study we
investigated the effect of whole human milk and its fractions immunoglobulin and non-immunoglobulin on
the adherence of ETEC strains possessing different CFs to Caco-2 cells, as well as the ability of sIgA and free
secretory component (fSC) to bind to bacterial superficial proteins. Pooled human milk from three donors
were fractionated by gel filtration and analyzed by SDS-PAGE. Our results revealed that whole human milk
and its proteins fractions, containing sIgA and fSC, inhibited adhesion ETEC strains harboring different
colonization factors antigens. We also verified that sIgA and fSC, using immunoblotting and immunogold
labeling assays, bound to some fimbrial proteins and other material present in bacterial surface. Our findings
suggest that whole human milk and its fractions may contribute to protection against ETEC infections by
blocking bacterial adhesion mediated by different colonization antigens.
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INTRODUCTION
Enterotoxigenic Escherichia coli (ETEC) is an important
cause of diarrhea among children in developing countries
(28,29) and among travelers to ETEC endemic areas (18). Two
virulence attributes that characterize ETEC are the colonization
of the small intestine surface and the production of enterotoxins.
It is well-known that in ETEC strains the colonization of
intestinal mucosa is related to the presence of specific fimbrial
antigens, called colonization factors (CFs) (10). Twenty one
different CFs have been described for human ETEC (12,26).
Among the most studied and frequently found CFs are CFA I,
CS1, CS2, CS3, CS4, CS5, CS6 and CS8 (12). Most of ETEC
isolated in Brazil have been shown to possess CFA I, CFA II
and CFA IV (14,17,27).
Epidemiological studies of diarrhea have shown that breast
feeding protects infants from intestinal infections (20,32). The
protective effect of human milk is usually attributed to its high
content of immunoglobulin, specially secretory
immunoglobulin A (sIgA) (6,16). Some works showed that sIgA
inhibit the adhesion of enteropathogenic Escherichia coli to
HeLa cells and Hep-2 (5,6,9), and possess effect against ETEC
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virulence factors (7,8). Recently, some studies of our group
demonstrated that sIgA inhibits the adherence of diffusely
adherent Escherichia coli (DAEC), enteroaggregative
Escherichia coli (EAEC) and Shigella flexneri to HeLa cells
(1,31).
Protection by human milk can also be ascribed to non-
immunoglobulin components such as free oligosaccharides,
glycolipids and glycoproteins (2,6,24). We demonstrated that
human milk glycoproteins, such as lactoferrin and free secretory
component (fSC), have the ability to inhibit adhesion of ETEC
CFA I+ strains to human erytrocytes (15).
The secretory component (SC) is found in several secretions
complexed with sIgA or as a free glycoprotein (22). It has been
shown that fSC is an 80 kDa glycoprotein, consisting of a
single polypeptide chain largely glycosilated (20%) (19). There
is little information about the role of fSC in secretions, but
some workers suggest that it may have a protective role against
diarrhea (4,15). Recently, using immunogold labeling, we
showed the ability of fSC to interact with CFA I and CFA II
(CS1 and CS3) fimbrial adhesins (25). To determine if the
interaction of milk proteins to bacterial superficial structures
could contribute to inhibition of ETEC adhesion, we
investigated the effect of whole human milk, immunoglobulin
fraction (IgF) and fSC on the adherence of ETEC strains
possessing CFA I, CS1, CS2, CS3, CS4, CS5, CS6 and CS8 to
intestinal cells. The binding of IgF and fSC to bacteria superficial
proteins also was investigated.
MATERIAL  AND METHODS
Bacterial strains
The phenotypes of all human ETEC strains used in this
work are shown in Table 1.
Breast milk samples
Human milk was obtained from the Human Milk Bank of the
Hospital Universitário de Brasília (Brasília, Brazil). Samples were
obtained from lactating mothers up to one month after delivery
and kept frozen -20ºC. Aliquots of individual milk samples were
taken from at least three donors and pooled.
Fractionation of human milk
The fractionation of pooled human milk was performed as
described previously by Giugliano et al. (15). Briefly, lipids and
casein were removed, and proteins concentrated by adding
ammonium sulfate to 70% saturation. The sample obtained was
dialyzed and applied to a Sephacryl S-200 HR column (2.6 x 80
cm; Pharmacia Biotech AB, Uppsala, Sweden) eluted with Tris-
HCl buffer, pH 7.6. Thereafter, the fractions eluted from each
peak were pooled and proteins were concentrated, dissolved
and dialyzed overnight against Tris-HCl buffer, pH 7.6. This
material was used in the adhesion inhibition assays.
Inhibition of bacterial adhesion assay
Caco-2 (8 x 104 cells/mL) cells (11), were grown in 24-well
tissue culture plates containing Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 15% fetal bovine serum
at 37ºC in 4% CO2, for at least 10 days. Bacterial strains were
grown in Luria Broth (LB) for 18 h at 37ºC. To study the effect
of human milk upon ETEC adherence, 40 µL bacterial culture
were previously exposed to 40 µL human milk or its fractions
for 30 min at room temperature. This mixture was added to the
wells of the tissue culture plates, containing confluent Caco-
2 cells grown in fresh DMEM supplemented with 0.5% D-
mannose. The plates were incubated for 1 h at 37ºC. The cells
were then washes three times with sterile phosphate buffered
saline (PBS). After treating the Caco-2 cells with a 0.02% tripsin-
EDTA solution, the cells were resuspended and counted in a
Neubauer chamber. The suspension, containing bacterial cells,
was diluted in PBS and inoculated in LB agar, in order to
determine the number of colony forming units (CFU) per cell.
All tests were performed in triplicate, and at least in three
different occasions. The effect of human milk and its fractions
was determined by calculating the mean number of bacteria
attached per cell. Bacterial cells incubated with PBS were used
as controls.
Statistical analysis
The results were expressed as mean number ± standard
deviations (SD) of bacteria adhering per cell. Statistical
significance was determined by using independent sample
t- Student test. The SPSS 10.0 program for Windows was
used.
Fimbriae purification
Fimbriae purification was performed as described by Mynott
et al. (23), with some modifications. To improve CFs expression,
Table 1. Bacterial samples.
Strains Serotype CFs Enterotoxins
H10407Ac O78:H11 CFA I, longus LT/ST
PB176b O6:H16 CS1, CS3 LT/ST
E4833b O6:H16 CS2, CS3 LT/ST
58R957b O6:H16 CS2 LT
E2539C1c O25:NM CS3, longus LT
61.1a O9:H10 CS8 LT
E11881Ec ND CS4, CS6, longus LT/ST
118299c ND CS5, CS6, longus ND
B7Ac O148:H28 CS6, longus LT/ST
aStrain from our bacterial collection; bStrains kindly provided by Dr.
B.C Guth, Universidade Federal de São Paulo, Brazil; cStrains kindly
provide by Dr. J.A. Girón, Universidad Autonoma de Puebla, Mexico;
ND- not determined.
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ETEC strains were grown in CFA agar (10) at 37ºC for 18 h. In
this conditions longus factor is not expressed since it requires
special culture conditions (13). Bacterial cells were harvested
and suspended in PBS. Fimbriae were detached from bacteria
by heat treatment in a shaking water bath at 65ºC for 20 min.
Bacterial cells were removed and the supernatant was
centrifuged at 39000g for 2 h at 4ºC, to remove outer-membrane
contaminants. The resulting supernantant was stored overnight
at 4ºC, to allow fimbrial aggregation and then centrifuged at
190387g for 2 h in a Hitachi (fixed rotor RP70T) ultracentrifuge
(Hitachi, Japan). The pellet, corresponding to the partially
purified fimbriae, was suspended in 500 µL of PBS (enriched
fimbrial preparation).
SDS-PAGE and immunoblotting analysis
The protein content was measured by the method described
by Bradford (3) and analysed by SDS-PAGE on acrylamide 12%
gels, as described by Laemmli (21). Gels were stained with
Coomassie brilliant blue G (Bio-Rad Laboratories, Hercules, CA,
USA).
After electrophoresis, proteins were transferred to
nitrocellulose membranes (Trans-Blot SD Semi-Dry CELL, Bio-
Rad Laboratories, Hercules, CA, USA) by the method described
by Towbin et al. (30). To verify the binding of IgF and fSC from
human milk to the fimbrial proteins, the membranes were
previously treated with human milk fractions overnight at 4ºC.
Subsequently, the membranes were incubated with specific anti-
SC, anti-goat IgG peroxidase conjugated and the reaction was
developed with 4-chloro-1-naphthol.
Immunolabeling assay and electron microscopy
The binding of human milk components to CFs were
determined by an immunological labeling assay, as described
previously (25). Briefly, enriched CFs fimbrial preparations were
exposed to human milk fractions for 1h at room temperature.
Afterwards, the fimbrial suspensions were placed on Formvar-
carbon-coated grids (200 mesh) (Electron Microscopy Sciences,
Fort Washington, USA). The grids were previously treated with
a blocking solution, containing 1% bovine serum albumin, 0.85%
NaCl, in 10 mM Tris-HCl buffer, pH 8.0. To verify the binding of
IgA and fSC to different colonization factors, the grids were
incubated with goat anti-SC serum, followed by anti-goat IgG
gold labeled (10 nm gold) and negatively stained with 2%
phosphotungstic acid, pH 7.2. Subsequently, the grids were
examined with a Jeol Jem 100 C or 1011 electron microscope
(Jeol, Japan).
Reagents, antibodies and culture medium
Reagents and antibodies were from Sigma (St. Louis, MO,
USA) and culture medium from Gibco (Grand Island, NY, USA),
Difco (Detroit, Michigan, USA) and VETEC (Rio de Janeiro, RJ,
Brazil).
RESULTS
Inhibition of the adhesion of ETEC strains to Caco-2 cells
Adhesion inhibition assays showed that whole human milk
inhibited the adhesion of seven of the nine ETEC strains to
Caco-2 cells (Table 2). The adherence of the strains possessing
CS2/CS3 and CS2 was not affected by whole milk, while in all
other adherent strains tested it was inhibited (P < 0.05). To
verify the effect of the human milk immunoglobulin (IgF) and
non-immunoglobulin (NIgF) fractions in the ETEC adhesion,
concentrated proteins of the whey were separated on a
Sephacryl S-200 HR column. A typical profile showing three
protein peaks was obtained, as previously reported (15).
Table 2. Inhibition of ETEC strains adherence to Caco-2 cells by whole human milk and its fractions.
Whole human milk IgF NIgF
CFs Control Treated P Control Treated P Control Treated P
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
CFA I 28.81 ± 8.17ª 12.66 ± 13.04ª >0.01 0.69 ± 0.72 0.35 ± 0.29 0.17 0.89 ± 0.70ª 0.34 ± 0.18ª 0.04
CS1/CS3 7.62 ± 9.10ª 1.80 ± 1.04ª 0.03 1.69 ± 1.62ª 0.57 ± 0.72ª 0.02 1.13 ± 0.50ª 0.51 ± 0.46ª 0.01
CS2/CS3 12.36 ± 20.47 18.18 ± 29.38 0.85 0.35 ± 0.16 0.44 ± 0.15 0.24 0.30 ± 0.16 0.40 ± 0.24 0.34
CS2 8.66 ± 12.16 2.25  ± 5.29 0.51 0.16 ± 0.08 0.21 ± 0.18 0.45 0.26 ± 0.20 0.39 ± 0.36 0.39
CS3 7.89 ± 10.45ª 15.2 ± 0.78ª 0.02 2.77 ± 5.07 1.09 ± 1.16 0.54 1.04 ± 0.50 1.31 ± 1.13 0.69
CS4/CS6 0.83 ± 0.71ª 0.11 ± 0.08ª >0.01 0.30 ± 0.21ª 0.14 ± 0.06ª 0.06 0.73 ± 0.94 0.42 ± 0.39 0.54
CS5/CS6 0.63 ± 0.50ª 0.17 ± 0.19ª 0.05 0.96 ± 0.70ª 0.42 ± 0.30ª 0.03 3.32 ± 2.07 2.13 ± 0.80 0.27
CS6 0.82 ± 0.93ª 0.15 ± 0.13ª 0.01 0.17 ± 0.08ª 0.09 ± 0.08ª 0.02 0.44 ± 0.15 0.34 ± 0.14 0.31
CS8 57.79 ± 44.26ª 18.19 ± 27.29ª 0.03 0.61 ± 0.35ª 0.31 ± 0.25ª 0.04 3.05 ± 2.81ª 1.87 ± 0.63ª 0.03
Results represent mean number ± SD of bacteria adhering per cell at least six determinations; ª The treatment was significantly different (P<0.05)
from the control. IgF - immunoglobulin fraction; NIgF - non-immunoglobulin fraction.
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Electrophoretic analysis of first peak revealed a typical profile
of sIgA, showing protein bands corresponding to the secretory
component, the heavy, light and J chains. SDS-PAGE of the
second peak showed a main protein band corresponding to the
free secretory component. Immunoglobulins were not detected
in this peak, since the band corresponding to the heavy chain
was absent. The presence of sIgA and fSC in these peaks was
confirmed by immunoblotting.
As shown in Table 2, the first peak, containing 0.5 mg/mL of
IgF, inhibited adherence of ETEC strains harbouring colonization
factor antigens CS1/CS3, CS4/CS6, CS5/CS6, CS6 and CS8 to
Caco-2 cells. Although, the P value for effect of IgF over CS4/
CS6 strain was 0.06 (Table 2), we considered that this fraction to
be effective in decreasing the adhesion of this strain. This
decision was taken because in statistical tests accepting the
null hypothesis in such cases could lead to a type II error higher
than rejecting it. Furthermore, as shown below, we have other
evidences of the action of IgF on this bacterial strain structure.
The NIgF eluted in the second peak, corresponding to 0.6 mg/
mL of fSC and others milk proteins, inhibited adhesion strains
possessing antigen I (CFA I), CS1/CS3, and CS8. The proteins
corresponding to the third eluted peak had no effect on bacterial
adherence (data not shown). Both IgF and NIgF were not able
to influence bacterial growth (31).
Binding of IgF and fSC to superficial bacterial proteins
To determine the binding of IgF and fSC to the ETEC CFs,
immobilized superficial bacterial proteins were exposed to
immunoglobulin or non-immunoglobulin fractions. Binding of
IgF and fSC were detected by immunoblotting analysis. The
binding profiles of the IgF and fSC to the superficial proteins
preparations were similar (Fig. 1B,C). We observed that IgF and
fSC bound strongly to protein bands with molecular masses
corresponding to CFA I (15.7 kDa), CS1 (17.3 kDa), CS3 (15.1
kDa), CS5 (21.8 kDa), CS6 (15.7 kDa) and bound weakly with a
protein band corresponding to CS8 antigen (18.7 kDa).
Futhermore, immunoblotting analysis revealed that both, IgF
and fSC, interacted with a superficial protein of ~40 kDa extracted
from the strains expressing in CFA I, CS4/CS6, CS5/CS6, CS6,
and CS8. Weak bindings on others protein bands also were
detected.
Binding of IgF and fSC to fimbrial structures
Immunogold labeling assays, performed with different CFs
preparations exposed to IgF, showed that both CS1/CS3 and
CS8 fimbriae preparations were labeled. We also observed some
scattered gold beads not bound to the fimbriae structure in
CS1/CS3, CS4/CS6, and CS8 fimbrial preparations. Our results
also revealed that IgF interacts with the extracellular amorphous
mass in CS4/CS6 preparation. Fig. 2 illustrates a representative
binding, observed in this study.
As previously reported (25), fSC binds to CFA I, CS1 and
CS3 fimbriae. In this work, fimbrial preparations exposed to
fSC revealed immunolabeling on fimbriae CS4/CS6 and CS8
preparations. We also observed that fSC has ability to
scattering binding on other bacterial surface material, similar
to IgF, present in both fimbrial preparations from CS4/CS6 and
CS8 strains.
Figure 1. SDS-PAGE (A) and immunoblots of fimbriae preparations reacted with secretory IgA (B) and fSC (C). Binding of IgA and
fSC to different colonization factors was revealed using specific anti-SC antibody. M, molecular mass markers; lane 1, CFA I; lane
2, CS1/CS3; lane 3, CS3; lane 4, CS4/CS6; lane 5, CS5/CS6; lane 6, CS6; lane 7, CS8. Arrow indicates the ~40 kDa protein. CFA I (15.7
kDa), CS1 (17.3 kDa), CS3 (15.1 kDa), CS5 (21.8 kDa), CS6 (15.7), CS8 (18.7 kDa).
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DISCUSSION
Continuing our studies on the adherence inhibition of ETEC
strains by human milk, we investigated the effect of whole milk and
its IgF and NIgF on the adhesion mediated by CFA I, CS1, CS2,
CS3, CS4, CS5, CS6, CS8 and their combinations, on tissue culture.
Our results revealed that the whole human milk affected the
adherence of most of the strains tested. Adhesion of the strain
possessing CFA I fimbriae, was inhibited by both, whole milk
and NIgF, but not by the IgF, indicating the importance of NIgF
on the adhesion of CFA I strains. These findings are corroborated
by our previous studies (15,25), showing that lactoferrin and
fSC present in the NIgF inhibit bacterial adhesion to erythrocytes,
binding to bacterial fimbriae.
In the cases of strains possessing CS1/CS3 and CS8 both,
IgF and NIgF, affected their adhesion, probably acting
synergistically. On the other hand, CS2/CS3 and CS2 strains
were not affected by whole milk, while the CS3 strain was
inhibited. Taken together, these results suggest a main role for
CS2, since the strains possessing this antigen alone or in
combination were not inhibited.
Interestingly, IgF and NIgF had no inhibitory effect on the
CS3 strain adhesion, indicating that non-protein components
of the milk, such as glycolipids and oligosaccharides, could be
involved on the inhibition of the adhesion of this strain.
We also observed that strains CS4/CS6, CS5/CS6 and CS6
were inhibited by whole milk and IgF. The incapacity of IgF to
inhibit four of the nine strains tested may be related the need of
a previous exposure of the mother to each pathogen. In this
sense, probably our milk pool did not have specific antibodies
directed to all of the colonization factors studied.
The mechanism by which milk compounds affect ETEC
adhesion may be related to their ability to interact with bacterial
surface molecules involved in adhesion. Therefore, to
investigate the molecular target of immunoglobulin of milk, and
the putative binding of fSC, immobilized bacterial surface
proteins were exposed to IgF and NIgF.
A similar binding profile of IgF and fSC was found with both
compounds, which bind to six colonization factors, indicating
that these antigens are important molecular targets involved in
the adhesion process. Immunoblotting analysis revealed that
both, IgF and fSC, bound to CFA I, although only fSC seems to
affect the adhesion of the CFA I strain, since the IgF did not
present any inhibitory effect on the adhesion of this strain. The
adhesion of the CS8 strain was inhibited by IgF and NIgF,
problably by the ability of immunoglobulin and fSC to bind to
CS8 fimbriae. We also observed that IgF and fSC bind to both,
CS5 and CS6 fimbriae from CS4/CS6 preparation; however, the
adhesion of the strains possessing CS4/CS6 and CS5/CS6
combinations was inhibited only by IgF. Binding of IgF and fSC
to the protein band corresponding to CS6 from CS5/CS6 and
CS6 strains fimbrial preparations was not detected. It is possible
that these preparations were not enriched enough with CS6
antigen, preventing its recognition by milk proteins isolated in
Figure 2. Representative immunogold labeling assay of the enriched fimbrial preparations. Binding pattern of fSC on CS4/CS6 (A),
CS8 (B) and on extracellular amorphous mass in CS4/CS6 preparation (C). Binding of fSC to different colonization factors was
revealed using specific anti-SC antibody. The arrows indicate the gold particles on fimbriae. The small arrowhead and large
arrowhead indicate scattered labeling and binding on amorphous mass, respectively. Bar, 0.2 mm.
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this study. We also did not observe binding of IgF and fSC to
CS4, suggesting that these proteins do not recognize this
antigen, and to CS3 strain, reinforcing our hypothesis that other
milk components could act as inhibitors of the bacterial adhesion
to Caco-2 cells.
Interestingly, we verified that both IgF and fSC bound to
other protein bands present in bacterial superficial protein
preparations, predominantly to a ~40 kDa protein, which seems
to be a common protein, possibly involved in the adhesion of
ETEC strains to eukaryotic cells.
In this study we have also investigated the binding of both,
IgF and fSC, to fimbrial structures, using immunocytochemistry
assays. Our results revealed that IgF interacts with CS1/CS3
and CS8 fimbriae, which seem to be important to the adhesion
process since both were inhibited in the adhesion assays. The
same result was observed with CFA I, CS1/CS3 (25) and CS8
exposed to fSC, indicating that this glycoprotein could play an
important role against ETEC strains harbouring these CFs. We
also verified that fSC binds to fimbrial structures present in
CS4/CS6 preparation, although this binding did not affect CS4/
CS6 strain adhesion to Caco-2 cells.
We also observed some gold beads showing a scattered or
aggregative labeling pattern on other celular material present in
some fimbrial preparations. This binding profile may be related
to the ~40 kDa protein and other bacterial surface proteins
recognized by IgF and fSC in the immunoblotting assay. Taken
together, our results suggest that bacterial adhesion to host
cells may involve fimbrial proteins, and probably other bacterial
superficial molecules. Further studies are necessary to determine
the actual role of these molecules present on bacterial surface.
Our findings reveal that active compounds from the human
milk, such as immunoglobulins and non-immunoglobulin
proteins can inhibit the adherence of several ETEC strains to
Caco-2 cells, with this mechanism probably playing an important
role in the protection of infants against enteric infections.
CONCLUSIONS
This study indicates that whole human milk and its
immunoglobulin and non-immunoglobulin fractions inhibit
ETEC strains adhesion to eukaryotic cells, a process mediated
by different colonization factors. Our findings suggest that
IgF and fSC can bind to different colonization factors from
ETEC, implicating these factors as important molecular targets
involved in the adhesion process. Moreover, we also verified
that both, IgF and fSC, bind to other bacterial superficial
proteins, specially to a ~40 kDa protein, which may be involved
in ETEC strains adhesion. The ability of IgF and fSC to interact
with fimbrial proteins and other superficial cellular material
indicates that specific antibodies and non-specific defense
factors from human milk may block ETEC strains adhesion to
host cell receptors.
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RESUMO
Inibição da adesão de Escherichia coli
enterotoxigênica (ETEC) as células CACO-2 pelo leite
humano e suas frações imunoglobulínica e não
imunoglobulínica
Escherichia coli enterotoxigênica (ETEC) é uma importante
causa de diarréia infantil em países em desenvolvimento e entre
os viajantes em áreas endêmicas. A diarréia por ETEC é causada
pela colonização do intestino delgado, mediada pelos fatores
antigênicos de colonização (CFs), e a subseqüente elaboração
de enterotoxinas. A amamentação tem sido relacionada com a
proteção contra infecções entéricas. O efeito protetor do leite
humano pode ser atribuído ao seu conteúdo imunoglobulínico,
especialmente a imunoglobulina A secretória (sIgA), e aos
componentes não imunoglobulínicos tais como oligossacarídeos
livres, glicoproteínas e glicolipídeos. Neste estudo nós
investigamos o efeito do leite humano total e suas frações
imunoglobulínica e não imunoglobulínica sobre a adesão de cepas
ETEC possuidoras de diferentes fatores de colonização as células
Caco-2, bem como a habilidade da sIgA e do componente secretor
livre (fSC) de se ligarem as proteínas da superfície bacteriana.
Uma mistura de leite de três doadoras foi fracionada por filtração
em gel e analisada por SDS-PAGE. Nossos resultados revelaram
que o leite humano total e suas frações protéicas, contendo sIgA
e fSC, inibiu a adesão de cepas ETEC albergando diferentes
fatores antigênicos de colonização. Nós também verificamos que
a sIgA e o fSC, usando ensaios de imunoeletrotransferência e
imunomarcação, ligaram-se a algumas proteínas fimbriais e a outro
material presente na superfície bacteriana. Nossos dados sugerem
que o leite humano total e suas frações podem contribuir para
proteção contra as infecções por ETEC bloqueando a adesão
bacteriana mediada pelos diferentes antígenos de colonização.
Palavras-chave: Diarréia; Inibição da adesão; Escherichia coli
enterotoxigênica; Fator antigênico de colonização; Leite humano
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